| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/03/2000 | CN1252064A Bicyclic amino acids |
| 05/03/2000 | CN1251992A Sulfated oligosacharides having anticoagulant/antithrombotic activity |
| 05/03/2000 | CN1251762A Process for preparing Chinese medicine 'Buxueyimu Particles' |
| 05/03/2000 | CN1051931C Compound preparation for nutritional iron-deficiency anemia |
| 05/02/2000 | US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates |
| 05/02/2000 | US6057336 Lactam metalloprotease inhibitors |
| 05/02/2000 | US6057318 Heterocyclic derivatives, process for their preparation and their therapeutic use |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057133 Fusion protein associated with cell growth and regulation; for the activation of bone marrow propagation; for treatment of cancer, asthma and inflammation |
| 05/02/2000 | US6057131 Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1) |
| 05/02/2000 | US6057128 MU-1, member of the cytokine receptor family |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056958 Administering a therapeutically effective amount of a monoclonal antibody having a laboratory designation selected from the group consisting of; lm609; 10c4.1.3; 9g2.1.3; and 9d1.9.1 |
| 05/02/2000 | CA2020838C Hemoregulatory peptides |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 04/30/2000 | CA2288386A1 Antithrombotic agents |
| 04/28/2000 | CA2287549A1 Antithrombotic agents |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023567A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/27/2000 | WO2000023471A2 Use of a cytokine-producing lactococcus strain to treat colitis |
| 04/27/2000 | WO2000023465A2 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | WO2000023430A1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 04/27/2000 | WO2000023421A1 (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/27/2000 | WO2000023116A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO2000023086A2 Buffered compositions for dialysis |
| 04/27/2000 | WO2000023078A1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds |
| 04/27/2000 | WO2000004895A3 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | CA2348068A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | CA2347792A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/27/2000 | CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2346500A1 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | CA2346152A1 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/26/2000 | EP0995755A1 Prodrugs of Thrombin inhibitors |
| 04/26/2000 | EP0995446A2 Antithrombin III-beta containing medical preparation |
| 04/26/2000 | EP0994947A1 Mu-1, member of the cytokine receptor family |
| 04/26/2000 | EP0994898A1 Integrin binding peptide and use thereof |
| 04/26/2000 | EP0994894A1 SELECTIVE FACTOR Xa INHIBITORS |
| 04/26/2000 | EP0994893A1 Selective factor xa inhibitors containing a fused azepinone structure |
| 04/26/2000 | EP0994892A1 SELECTIVE FACTOR Xa INHIBITORS |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994861A1 NEW $g(b)-AMINO AND $g(b)-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 04/26/2000 | EP0994711A1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and rnal function |
| 04/26/2000 | EP0832130B1 Separating polymerized from unpolymerized hemoglobin using hydroxyapatite |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | CN1251532A Tissue factor methods and compositions for coagulation and tumor treatment |
| 04/26/2000 | CN1051714C Patent medicine of traditional Chinese medicine and preparation method |
| 04/25/2000 | US6054486 Use of 9-Deoxy-2',9-α-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f1 to treat peripheral vascular disease |
| 04/20/2000 | WO2000022143A2 Protein kinase homologs |
| 04/20/2000 | WO2000022126A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | WO2000021977A1 Pregnane glucuronides |
| 04/20/2000 | WO2000021954A1 Novel heterocyclyl-methyl-substituted pyrazoles |
| 04/20/2000 | WO2000021932A1 NEW PROCESSES FOR PRODUCING β-ALANINE DERIVATIVE |
| 04/20/2000 | WO2000021930A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-[2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 |
| 04/20/2000 | WO2000021591A1 Method for production of stroma-free hemoglobin |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | DE19847823A1 New 3-(Hetero)aryl-5-aminosulfonyl-1,2,4-thiadiazole derivatives useful as inhibitors of IL-1beta production in treatment of e.g. leukemia, septic shock, hepatitis, AIDS and diseases of locomotor system |
| 04/20/2000 | DE19846514A1 New arylmethyl and heterocyclylmethyl substituted heteroaryl-indazole derivatives useful in treatment of cardiovascular, ischemic and urogenital disorders |
| 04/20/2000 | CA2347968A1 Follistatin-related protein zfsta2 |
| 04/20/2000 | CA2346775A1 Protein kinase homologs |
| 04/20/2000 | CA2346698A1 Novel heterocyclyl-methyl-substituted pyrazoles |
| 04/20/2000 | CA2346693A1 Pregnane glucuronides |
| 04/20/2000 | CA2346433A1 New processes for producing .beta.-alanine derivative |
| 04/19/2000 | EP0993311A2 Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof |
| 04/19/2000 | EP0993300A1 Antithrombotic agents |
| 04/19/2000 | EP0880524B1 Adenosin antagonists, method of preparing them and their use as drugs |
| 04/19/2000 | CN1251133A Bi or multifunctional molecules based on dendroaspin scaffold |
| 04/19/2000 | CN1251095A Lipase capalyzed dynamic resolution of isoxazoline thioester to isoxazoline carboxylic acids |
| 04/19/2000 | CN1250660A Liquid medicine for treating wound and pain |
| 04/18/2000 | USRE36665 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 04/18/2000 | US6051584 Viricides; fungicides; bactericides |
| 04/18/2000 | US6051577 N-7-heterocyclyl pyrrolo[2,3-D]pyrimidines and the use thereof |
| 04/18/2000 | US6051568 Thrombin inhibitors, their preparation and use |
| 04/18/2000 | US6051402 A nucleic acid encoding an anti-sickling beta-globin protein; gene therapy for sickle cell |
| 04/18/2000 | US6051223 Mixing with anionic polymer, acid, amine or their salts |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | CA2071956C Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor |
| 04/13/2000 | WO2000020453A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020416A1 Imidazo[4,5-c-]-pyridine-4-one derivatives with factor xa inhibiting effect |
| 04/13/2000 | WO2000020395A1 New crystal modification iii of torasemide |
| 04/13/2000 | WO2000020394A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | WO2000020378A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 04/13/2000 | WO2000020053A1 Biological fluid filter and system |
| 04/13/2000 | WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | WO2000019976A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 04/13/2000 | WO1999061072A3 Methods of inhibiting clot formation |
| 04/13/2000 | CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin |
| 04/13/2000 | CA2346033A1 Imidazo[4,5-c-]-pyridin-4-one(sic) derivatives having factor xa-inhibiting action |
| 04/13/2000 | CA2345997A1 Benzamide derivatives as thrombin inhibitors |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345789A1 New crystal modification iii of torasemide |
| 04/13/2000 | CA2345535A1 Biological fluid filter and system |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |